share_log

开拓药业-B(09939.HK)8月26日举行董事会会考虑及批准中期业绩

Kaituo Pharmaceutical-B (09939.HK) held a board of directors meeting on August 26 to consider and approve its interim performance.

Gelonghui Finance ·  Aug 9 04:33

Kaituo Pharmaceutical-B (09939.HK) announced on August 9 that the board of directors meeting will be held on August 26, 2024 (Monday) to consider and approve the mid-term performance of the company and its subsidiaries ending on June 30, 2024, including its release.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment